Data
- - - Truveta Data
      
      A complete, living view of patient care
    - Explore Truveta Data
  - - Capabilities
      
      Representative, complete, and real-time
  - - Evidence
      
      Build trust through rigorous analytics and expertise
    - - Trusted research environment
      - Evidence Services
Intelligence
- - - Truveta Intelligence
      
      Answers in minutes, not months
    - Explore Truveta Intelligence
  - - Capabilities
      
      Ask what matters now
    - - Ask
  - - Evidence
      
      Verify the methodology behind the results
    - - Verify
Customers
- - - Truveta customers
      
      Trusted by leading life science, public health, and healthcare organizations
  - - Who we serve
Research
About
- - - Saving Lives with Data
      
      Built with and owned by US health systems to improve patient care
Contact us
Sign in



Close

Research

Featured research

Hantavirus remains extremely rare in the US — but severe when it occurs • Since 2018, roughly 0.5 hantavirus cases per 1 million patients seeking care were identified. • Nearly half of patients with hantavirus were hospitalized within first 14 days.

Hantavirus remains extremely rare in the US — but severe when it occurs

Since 2018, roughly 0.3 hantavirus cases per 1 million patients seeking care each quarter were identified. Nearly half of patients with hantavirus were hospitalized within first 14 days. Of patients who were hospitalized, 85% were hospitalized prior to diagnosis or...

Estrogen-based hormone replacement therapy use is rising

Estrogen-based hormone replacement therapy use is rising

Estrogen-based hormone replacement therapy (HRT) prescribing more than doubled from 2018 to 2026. The largest increases were seen in patches and vaginal creams, with patch use more than tripling and vaginal cream use increasing more than fourfold. The rates of women...

Featured research topics

GLP-1

Oncology

Flu/RSV

Measles

Cardiovascular